ArticleCancer causes & control : CCC2025
Opioid prescription and usage disparities among Puerto Rican breast cancer survivors: findings from the Puerto Rico central cancer registry-health insurance linkage database (PRCCR-HILD).
Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeHispanic/Latina breast cancer patients receive fewer opioid prescriptions for cancer-related pain. The primary aim of this study was to explore opioid prescription rates among Hispanic/Latina breast cancer survivors living in Puerto Rico.
methodsThis cross-sectional study analyzed opioid prescription use in a retrospective cohort of Puerto Rican breast cancer women using the Puerto Rico Central Cancer Registry-Health Insurance Linkage Database. Adjusted odds ratios and incidence rate ratios with 95% confidence intervals were estimated using logistic and negative binomial regression analyses to assess factors associated with the use and frequency of opioids use.
resultsPuerto Rican breast cancer survivors, mostly 40-64 years old were included (n = 1,733). Opioid prescription three years following their breast cancer diagnosis was 13.1%. Participants enrolled in Medicare (AOR = 9.77) and dually eligible for Medicare-Medicaid (AOR = 5.54), with a comorbidity index of 1 (AOR = 1.50), with a history of opioid use before their cancer diagnosis (AOR = 2.49), and that received chemotherapy (AOR = 1.47) were more likely to be prescribed opioids. Analyses in rates of opioid prescription revealed statistically significant increases among those enrolled in Medicare (IRR = 17.51) and dually eligible for Medicare-Medicaid (IRR = 11.74) and for those with a history of opioid prescription before diagnosis (IRR = 4.16).
conclusionFuture research should explore how factors such as structural racism and geographic isolation shape opioid prescription and usage among breast cancer survivors living in Puerto Rico.
Indexed as
Identifiers
40610680What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.